THE BLOOD IN CANCER SUBJECTS 



269 



Here, it will be observed, there is substantial uniformity be- 

 tween the two counts except as regards three factors : namely ( 1 ) 

 the total leucocyte count, which was 9,500 in the second patient 

 against 8,000 in the first ; (2) the polynuclear count, which was 

 69.5 against 60; and (3) the large monocyte count which was 

 14.5 against 23.5. These differences, however, are highly sig- 

 nificant, in view of the studies of the blood count above outlined. 



TABLE VIII ORIGINAL CASES 



THE SAME 31 UNSELECTED CASES AFTER AN AVERAGE OP 152 DAYS OF 

 PROTEIN TREATMENT 



Comparison with the preceding table will show characteristic progress during this period 

 of fourth and fifth months (on the average) of Proteal treatment. 



Nothing more would have been necessary to make the two 

 counts identical as to their leucocyte percentage balance than to 

 take the 9.5 per cent, in excess of polymorphs in the second case 

 and transfer them to the large monocyte column. I am greatly 

 disposed to believe that had the Proteal treatment been able to 

 effect such a modification of blood count, there would have been 

 a modification in the production of the leucocytic enzymes that 

 might have turned the scale in the patient's favor. As it was, 

 however, the second patient developed a small metastasis in the 

 neck while undergoing the treatment, which so alarmed her that 



